Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription Articles published in Pathology Retrieve available abstracts of 19 articles: HTML format

Single Articles

April 2024
1. ZENGIN HB, Tan PH, Liu R, Smoller BR, et al
   'Eczematous' dermatitis of the nipple: clinical and histopathological differential diagnosis of Paget disease.
   Pathology. 2024;56:300-312.
   PubMed     Abstract available
   
   
   
2. TAY TKY, Tan GS, Lee SH, Sam XX, et al
   Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers.
   Pathology. 2024;56:325-333.
   PubMed     Abstract available
   
   
   March 2024
3. WU Y, Chen F, Pan L, Chao X, et al
   Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
   Pathology. 2024 Mar 14:S0031-3025(24)00084-9. doi: 10.1016/j.pathol.2024.
   PubMed     Abstract available
   
   
   
4. KRYSTEL-WHITTEMORE M, Tan PH, Wen HY
   Predictive and prognostic biomarkers in breast tumours.
   Pathology. 2024;56:186-191.
   PubMed     Abstract available
   
   
   January 2024
5. BAEZ-NAVARRO X, van Bockstal MR, Jager A, van Deurzen CHM, et al
   HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study.
   Pathology. 2024 Jan 18:S0031-3025(24)00007-2. doi: 10.1016/j.pathol.2023.
   PubMed     Abstract available
   
   
   October 2023
6. ZENG L, Koh VCY, Tay TKY, Lee AC, et al
   Adenoid cystic carcinoma arising in association with an intraductal papilloma of the breast.
   Pathology. 2023;55:895-897.
   PubMed    
   
   
   August 2023
7. CHEN YY, Yang CF, Hsu CY
   The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer.
   Pathology. 2023 Aug 12:S0031-3025(23)00186-1. doi: 10.1016/j.pathol.2023.
   PubMed    
   
   
   
8. NGUYEN MA, Colebatch AJ, Van Beek D, Tierney G, et al
   NTRK fusions in solid tumours: what every pathologist needs to know.
   Pathology. 2023;55:596-609.
   PubMed     Abstract available
   
   
   June 2023
9. TAN PH
   Refining the classification of breast phyllodes tumours.
   Pathology. 2023;55:437-448.
   PubMed     Abstract available
   
   
   April 2023
10. NAMJOSHI A, Wong DD, Gill J
    A rare case of metastatic endometrial stromal sarcoma mimicking primary breast carcinoma: a diagnostic pitfall.
    Pathology. 2023;55:414-416.
    PubMed    
    
    
    October 2022
11. TSANG JY, Shao Y, Poon IK, Ni YB, et al
    Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
    Pathology. 2022;54:678-685.
    PubMed     Abstract available
    
    
    
12. HARB M, Prince DS, Bassan M, Mackenzie S, et al
    Extra-mammary Paget's disease rising from a non-invasive rectal adenoma.
    Pathology. 2022;54:826-828.
    PubMed    
    
    
    April 2022
13. ROY SF, Wong J, Latour M, Reichetzer B, et al
    Ductal-type mesonephric duct/remnant hyperplasia: distinguished from lobular or diffuse mesonephric hyperplasia by the presence of a myoepithelial cell layer and micropapillary tufting.
    Pathology. 2022;54:378-381.
    PubMed    
    
    
    February 2022
14. LEE W, Law T, Lu Y, Lee TK, et al
    Mitotic counts in one high power field in breast core biopsies is equivalent to counts in 10 high power fields.
    Pathology. 2022;54:43-48.
    PubMed     Abstract available
    
    
    
15. KATAYAMA A, Toss MS, Parkin M, Ellis IO, et al
    Atypia in breast pathology: what pathologists need to know.
    Pathology. 2022;54:20-31.
    PubMed     Abstract available
    
    
    
16. HORT A, O'Toole SA, Yunaev M
    An unusual case of invasive lobular carcinoma with abundant extracellular mucin.
    Pathology. 2022;54:138-140.
    PubMed    
    
    
    January 2022
17. KUNC M, Peksa R, Cserni G, Izycka-Swieszewska E, et al
    High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.
    Pathology. 2022 Jan 21. pii: S0031-3025(21)00542.
    PubMed     Abstract available
    
    
    February 2021
18. PAVER EC, Cooper WA, Colebatch AJ, Ferguson PM, et al
    Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
    Pathology. 2021;53:141-156.
    PubMed     Abstract available
    
    
    
19. RAZVI H, Tsang JY, Poon IK, Chan SK, et al
    INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Pathology. 2021;53:170-178.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.